Andreas D. Meid

1.3k citations

59 papers · 830 indexed · h-index 17

Impact in

Geriatrics and Gerontology top 0.5%
- Pharmaceutical Practices and Patient Outcomes
- Frailty in Older Adults
Family Practice top 2%
- Medication Adherence and Compliance

Papers in

Geriatrics and Gerontology 24
- Pharmaceutical Practices and Patient Outcomes 24
Family Practice 9
- Medication Adherence and Compliance 9

Co-authors: Walter E. Haefeli Hermann Brenner Ben Schöttker Bernd Holleczek Kai‐Uwe Saum Klaus Hauer Hans‐Helmut König Hanna M. Seidling
Journals: PLoS ONE (6 papers)European Journal of Clinical Pharmacology (4 papers)Drug Safety (3 papers)British Journal of Clinical Pharmacology (3 papers)Frontiers in Pharmacology (3 papers)
Partner nations: Germany United States United Kingdom

In The Last Decade

Andreas D. Meid

55 papers receiving 805 citations

Peers

Countries citing papers authored by Andreas D. Meid

Since Specialization

Citations

This map shows the geographic impact of Andreas D. Meid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas D. Meid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas D. Meid more than expected).

Fields of papers citing papers by Andreas D. Meid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas D. Meid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas D. Meid. The network helps show where Andreas D. Meid may publish in the future.

Co-authors

The 25 scholars most cited alongside Andreas D. Meid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Andreas D. Meid Line = papers co-authored together Andreas D. Meid links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Effect of the frequently used antiepileptic drugs carbamazepine, gabapentin, and pregabalin on the pharmacokinetics of edoxaban and other oral factor xa inhibitors in healthy volunteers Frontiers in Pharmacology ·Seunghun Han, ZENG Deqiang, 康司許斐, Jürgen Burhenne, Kathrin I. Foerster, David Czock, Gerd Mikus, Andreas D. Meid, Walter E. Haefeli, Antje Blank	2025	0
2	Testing Higher Doses of Sildenafil to Repair Brain Injury Secondary to Birth Asphyxia: An Open-Label Dose-Finding Phase 1b Clinical Trial–Sildenafil Administration to Treat Neonatal Encephalopathy–Study 02 The Journal of Pediatrics ·Pia Wintermark, Anie Lapointe, Gabriel Altit, Robin H. Steinhorn, Emmanouil Rampakakis, Andreas D. Meid, Jürgen Burhenne, 吉宏福田, May Khairy, Gaelle Lemardelay, Guillaume Gilbert, Nurfarhana Abu Bakar, Samara Zavalkoff, Thuy Mai Luu, Verhagen Johan, Walter E. Haefeli	2025	1
3	Event Analysis for Automated Estimation of Absent and Persistent Medication Alerts: Novel Methodology JMIR Medical Informatics ·Jeffrey A. Farrar, 武彦佐生, Andreas D. Meid, Walter E. Haefeli, Hanna M. Seidling	2024	1
4	Effect of Tacrolimus Formulation (Prolonged‐Release vs Immediate‐Release) on Its Susceptibility to Drug‐Drug Interactions with St. John's Wort Clinical Pharmacology in Drug Development ·정제원, Omini G. E I. E. Ele, Max Sauter, Andreas D. Meid, Jürgen Burhenne, Johanna Weiß, Antje Blank, Walter E. Haefeli, David Czock	2024	2
5	Real-World Application of a Quantitative Systems Pharmacology (QSP) Model to Predict Potassium Concentrations from Electronic Health Records: A Pilot Case towards Prescribing Monitoring of Spironolactone Pharmaceuticals ·Andreas D. Meid, 武彦佐生, Oriane Stévart, David Czock, Hanna M. Seidling	2024	0
6	Coadministration of fluconazole to boost subtherapeutic sirolimus concentrations: A case report Pharmacology Research & Perspectives ·武彦佐生, Andreas D. Meid, H. H. Chen, Garnett Annschultz, Johanna Weiß, David Czock, Walter E. Haefeli	2024	1
7	CYP3A and CYP2C19 Activity Determined by Microdosed Probe Drugs Accurately Predict Voriconazole Clearance in Healthy Adults Clinical Pharmacokinetics ·Hitoshi KOMAKI, Antje Blank, Andreas D. Meid, Kathrin I. Foerster, 康司許斐, Jürgen Burhenne, Walter E. Haefeli, Gerd Mikus	2023	4
8	Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin Cardiovascular Drugs and Therapy ·大亀浩久, Bao-Qu Zhang, 康司許斐, 정제원, Supatra Phokaeo, Gerd Mikus, Max Sauter, Jürgen Burhenne, Johanna Weiß, Andreas D. Meid, David Czock, Antje Blank, Walter E. Haefeli	2023	1
9	Anticholinergic burden measures, symptoms, and fall-associated risk in older adults with polypharmacy: Development and validation of a prognostic model PLoS ONE ·信之西川, Andreas D. Meid, Henrik Rudolf, Maria-Sophie Brueckle, Ana Isabel González‐González, Z. Begić, Hongan Shi, Kym I E Snell, Petra J. M. Elders, Ji-Yeon Baek, Norbert Donner‐Banzhoff, Jeanet W. Blom, Marjan van den Akker, Ferdinand M. Gerlach, Sebastian Harder, Ulrich Thiem, Paul Glasziou, Walter E. Haefeli, Christiane Muth	2023	4
10	Prevalence and patient-rated relevance of complexity factors in medication regimens of community-dwelling patients with polypharmacy European Journal of Clinical Pharmacology ·زايد علي عبد الخالق المنزوع, Steffen J. Schmidt, Anette Lampert, Gaiqin Zhu, Andreas D. Meid, Г. С. Неталиева Г. С., Oriane Stévart, Stefan Wilm, Achim Mortsiefer, Arul Pragasam, Attila Altiner, Razzaq Abdul Manan, Joachim Szécsényi, Frank Peters-Klimm, Petra Kaufmann‐Kolle, Petra Thürmann, Walter E. Haefeli, Hanna M. Seidling	2022	4
11	Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion Clinical Pharmacokinetics ·魯参池田, Nicolas Hohmann, Robin Michelet, Liu Ruijie, Andreas D. Meid, Jürgen Burhenne, Wilhelm Huisinga, Walter E. Haefeli, Gerd Mikus, Charlotte Kloft	2022	10
12	A prediction model for nonpersistence or nonadherence to direct oral anticoagulants in hospitalized patients with atrial fibrillation Journal of Managed Care & Specialty Pharmacy ·周美平, Lynette R. Neumann, Walter E. Haefeli, Andreas D. Meid	2022	3
13	Low Exposure to Direct Oral Anticoagulants Is Associated with Ischemic Stroke and Its Severity Journal of Stroke ·Timolaos Rizos, Andreas D. Meid, Andrea Huppertz, И.А. Чижова, Jan Purrucker, Kathrin I. Foerster, Jürgen Burhenne, David Czock, Ekkehart Jenetzky, Peter A. Ringleb, Walter E. Haefeli	2022	11
14	Wie vollständig ist der Bundeseinheitliche Medikationsplan? Eine Analyse bei Krankenhausaufnahme DMW - Deutsche Medizinische Wochenschrift ·Yabin Li, Premysl Bercik, Andreas D. Meid, G Rymaszewska, Torsten Hoppe‐Tichy, Walter E. Haefeli, Hanna M. Seidling	2020	6
15	Composite midazolam and 1′-OH midazolam population pharmacokinetic model for constitutive, inhibited and induced CYP3A activity Journal of Pharmacokinetics and Pharmacodynamics ·Sabrina Wiebe, Andreas D. Meid, Gerd Mikus	2020	5
16	Reporter cell assay-based functional quantification of TNF-α-antagonists in serum – a proof-of-principle study for adalimumab Analytical Biochemistry ·Vogt Steffen, Max Sauter, Philipp Uhl, Andreas D. Meid, Walter E. Haefeli, Johanna Weiß, Dirk Theile	2020	2
17	Pain severity and analgesics use in the community-dwelling older population: a drug utilization study from Germany European Journal of Clinical Pharmacology ·Hyoukjae Lim, W. PAUL KORY, Li‐Ju Chen, Walter E. Haefeli, Andreas D. Meid, Hermann Brenner, Ben Schöttker	2020	3
18	Rivaroxaban and macitentan can be coadministered without dose adjustment but the combination of rivaroxaban and St John's wort should be avoided British Journal of Clinical Pharmacology ·Andrea Huppertz, Noemi E Lee, Andreas D. Meid, Kathrin I. Foerster, Jürgen Burhenne, David Czock, Gerd Mikus, Walter E. Haefeli	2018	19
19	Prediction of Drug-Related Risks Using Clinical Context Information in Longitudinal Claims Data Value in Health ·Andreas D. Meid, Andreas Groll, Dirk Heider, Paula Carolina Leite Walker, W. T. Welford, Christian Günster, Hans‐Helmut König, Walter E. Haefeli	2018	7
20	Association of preventable adverse drug events with inpatients' length of stay-A propensity-matched cohort study International Journal of Clinical Practice ·Yabin Li, Andreas D. Meid, 袁长玲, M. Thalheimer, Torsten Hoppe‐Tichy, Walter E. Haefeli, Hanna M. Seidling	2017	25

About Andreas D. Meid

Andreas D. Meid is a scholar working on Geriatrics and Gerontology, Family Practice, Cardiology and Cardiovascular Medicine, Transplantation and Pharmacology, having authored 59 papers that have together received 830 indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (24 papers), Health Systems, Economic Evaluations, Quality of Life (15 papers), Medication Adherence and Compliance (9 papers), Atrial Fibrillation Management and Outcomes (7 papers), Pharmacogenetics and Drug Metabolism (6 papers), Pharmaceutical studies and practices (6 papers), Blood Pressure and Hypertension Studies (5 papers) and Heart Failure Treatment and Management (5 papers). The work is most often cited by research in Geriatrics and Gerontology (390 citations), Family Practice (105 citations), Toxicology (48 citations), Economics and Econometrics (240 citations) and Cardiology and Cardiovascular Medicine (196 citations). Andreas D. Meid has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Walter E. Haefeli, Hermann Brenner, Ben Schöttker, Bernd Holleczek, Kai‐Uwe Saum, Klaus Hauer, Hans‐Helmut König, Hanna M. Seidling, Dirk Heider and Renate Quinzler. Their work appears in journals such as PLoS ONE, European Journal of Clinical Pharmacology, Drug Safety, British Journal of Clinical Pharmacology and Frontiers in Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact